I think MMR is 15-20% of the sporadic population and in ~100% for those with Lynch (which is about 5% of the total).
Usually chemo/radiation therapies are stopped when immunotherapies are used because there's little to no data on their interaction and tolerability.
Bearing in mind in nearly all cases immuniotherapies are used in trial stages or compassionate grounds.
I think MMR is 15-20% of the sporadic population and in ~100%...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.8¢ |
Change
0.003(2.00%) |
Mkt cap ! $54.11M | |||
| Open | High | Low | Value | Volume |
| 12.5¢ | 13.5¢ | 12.5¢ | $100.8K | 776.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 710395 | 12.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.0¢ | 424086 | 3 |
View Market Depth
| Last trade - 15.58pm 21/06/2024 (20 minute delay) ? |
| SRX (ASX) Chart |